03:33 AM EDT, 08/07/2024 (MT Newswires) -- agilon health (AGL) reported late Tuesday a Q2 net loss from continuing operations of $0.07 per share, wider than a loss of $0.04 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.08.

Revenue for the quarter ended June 30 was $1.48 billion, up from $1.07 billion a year earlier.

Analysts surveyed by Capital IQ expected $1.56 billion.

The company expects Q3 revenue of $1.47 billion to $1.48 billion. Analysts polled by Capital IQ are expecting $1.5 billion.

For 2024, the company now expects revenue of $6.01 billion to $6.04 billion, compared with the previous guidance of $6.13 billion to $6.18 billion. Analysts polled by Capital IQ are expecting $6.1 billion.

Price: 6.40, Change: +0.18, Percent Change: +2.89